北京艾普瑞特科技有限公司 Company Information
Company Name:
Beijing I-puritech Science & Technology Co.,Ltd
Tel:
-
Email:
zhangping@i-puritech.com
Nationality:
China
WebSite:
www.i-puritech.com
Product List:
69
1
Product List
ubicromenol
2382-48-1
Doramectin Impurity6
Doramectin Impurity4
Polymyxin E3
Notoginsenoside R1
80418-24-2
Milbemycin Oxime A4
93074-04-5
Ivermectin EP impurity G
73162-95-5
Ivermectin EP impurity I
1135339-49-9
N6-D-gluconoyl-L-lysine
94071-01-9
Doramectin Impurity7
Polymyxin B1-l
erythromycin F
82230-93-1
Ginsenoside Rd
52705-93-8
3″-N-demethylerythromycin A
992-62-1
Doramectin Impurity1
Vancomycin EP Impurity F
Vancomycin EP Impurity K
Abamectin B1b
65195-56-4
N-(2-aminoethyl)-4-tert-butyl-2,6-xylylacetamide
94266-17-8
erythromycin A enolether
33396-29-1
3-butyr-4B propionate-Sineptina V
Meleumycin B2
Bacitracin A
55852-84-1
Vancomycin EP Impurity H
Ivermectin H2B1b
70209-81-3
Daptomycin RS8a
Bacitracin D1
20-oxomilbemycin A4
86691-97-6
Linear DaptoMycin
88399-21-7
Bacitracin F
22601-63-4
Polymyxin B2
34503-87-2
Polymyxin E2
7239-48-7
Milbemectin A3
51596-10-2
Bacitracin B2
57762-78-4
Vancomycin EP Impurity G
Vancomycin EP Impurity L
Bacitracin A
22601-59-8
Midecamycin A2
Ginsenoside Re
52286-59-6
Polymyxin E1
7722-44-3
Ivermectin EP impurity H
71837-27-9
Abamectin B1a
65195-55-3
Vancomycin EP Impurity I
Bacitracin B3
Bacitracin Z
3, 4B-dipropionate-leucomycinV
Polymyxin B3
71140-58-4
Vancomycin EP Impurity C
Bacitracin B1
57762-79-5
erythromycin C
1675-02-1
Doramectin Impurity5
2560603-30-5
Midecamycin A3
36025-69-1
Ginsenoside Rb1
41753-43-9
Milbemycin Oxime A3
114177-14-9
Daptomycin Anhydrous
121869-35-0
Daptomycin beta-Isomer
123180-72-3
Ivermectin EP impurity K
74567-01-4
Ginsenoside Rg1
22427-39-0
Milbemectin A4
51596-11-3
Daptomycin RS2
542-32-5
anhydroerythromycin A
23893-13-2
erythromycin E
41451-91-6
Polymyxin B1
4135-11-9
Sineptina V
Polymyxin E1-7MOA
Vancomycin EP Impurity E
555598-85-1
Sineptina A6
N2-D-gluconoyl-L-lysine
94071-00-8
Ivermectin H2B1a
71827-03-7
1
Copyright 2007© ChemicalBook. All rights reserved.